Abstract

Accurate identification of lesions and their use across different medical institutions are the foundation and key to the clinical application of automatic diabetic retinopathy (DR) detection. Existing detection or segmentation methods can achieve acceptable results in DR lesion identification, but they strongly rely on a large number of fine-grained annotations that are not easily accessible and suffer severe performance degradation in the cross-domain application. In this paper, we propose a cross-domain weakly supervised DR lesion identification method using only easily accessible coarse-grained lesion attribute labels. We first propose the novel lesion-patch multiple instance learning method (LpMIL), which leverages the lesion attribute label for patch-level supervision to complete weakly supervised lesion identification. Then, we design a semantic constraint adaptation method (LpSCA) that improves the lesion identification performance of our model in different domains with semantic constraint loss. Finally, we perform secondary annotation on the open-source dataset EyePACS, to obtain the largest fine-grained annotated dataset EyePACS-pixel, and validate the performance of our model on it. Extensive experimental results on the public dataset FGADR and our EyePACS-pixel demonstrate that compared with the existing detection and segmentation methods, the proposed method can identify lesions accurately and comprehensively, and obtain competitive results using only coarse-grained annotations.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.